Camlin Fine Sciences Limited (CAMLINFINE.BO)
INR 123.2
(-0.32%)
INR 123.2
(-0.32%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 674.31 Million | 508.98 Million | 1.45 Billion | 1.17 Billion | 860.19 Million | -89.96 Million |
| Net Income | -927.53 Million | 803.77 Million | 939.78 Million | 1.05 Billion | 582 Million | 166.92 Million |
| Depreciation & Amortization | 786.06 Million | 625.12 Million | 559.64 Million | 442.94 Million | 328.02 Million | 289.93 Million |
| Deferred income taxes | - | 40.87 Million | -455.2 Million | -116.42 Million | -60.72 Million | -108.47 Million |
| Stock-based compensation | 90 Thousand | 23.59 Million | 73.89 Million | 45.26 Million | 4.43 Million | -307 Thousand |
| Change in working capital | 316.71 Million | -1.38 Billion | 41.7 Million | -659.31 Million | -412.46 Million | -798.25 Million |
| Other non-cash items | 2.07 Billion | 403.48 Million | 294.65 Million | 410.38 Million | 418.9 Million | 360.2 Million |
| Investing Cash Flow | -677.26 Million | -1.24 Billion | -2.49 Billion | -1.32 Billion | -901.17 Million | -19.38 Million |
| Investments in PPE | -605.75 Million | -1.44 Billion | -2.13 Billion | -838.74 Million | -1.34 Billion | -693.52 Million |
| Acquisitions | 5.58 Million | 9 Million | -655.35 Million | 678 Thousand | 1.41 Million | 2.02 Million |
| Investment purchases | -77.92 Million | -7.33 Million | - | -504 Million | -821 Thousand | -406.45 Million |
| Sales/Maturities of investments | 830 Thousand | 288.38 Million | 284.99 Million | - | 411.42 Million | 1.03 Billion |
| Other Investing Activities | -59.22 Million | -93.22 Million | 16.98 Million | 13.51 Million | 28.2 Million | 41.6 Million |
| Financing Cash Flow | -131.92 Million | 596.58 Million | 1.35 Billion | 386.26 Million | 32.5 Million | 256.72 Million |
| Debt repayment | -252.13 Million | -1.33 Billion | -760.59 Million | -229.16 Million | -507.41 Million | -886.73 Million |
| Dividends payments | -281.3 Million | -138.5 Million | -7.12 Million | -54.23 Million | -27.96 Million | -62.37 Million |
| Common Stock Repurchased | - | 2.66 Billion | -335.08 Million | -491.83 Million | - | 1.77 Billion |
| Common Stock Issuance | 5.8 Million | 5.46 Million | 948.43 Million | 757.32 Million | - | 1.64 Million |
| Other Financing Activities | -720.2 Million | -601.53 Million | 1.51 Billion | 404.17 Million | 567.89 Million | -569.28 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 316.71 Million | -1.38 Billion | 41.7 Million | -659.31 Million | -412.46 Million | -798.25 Million |
| Cash at beginning of period | 938.16 Million | 1.07 Billion | 755.19 Million | 523.66 Million | 532.13 Million | 384.76 Million |
| Cash at end of period | 935.32 Million | 937.42 Million | 1.07 Billion | 755.19 Million | 523.66 Million | 532.13 Million |
| Capital Expenditure | -605.75 Million | -1.44 Billion | -2.13 Billion | -838.74 Million | -1.34 Billion | -693.52 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -2.83 Million | -140.69 Million | 322.92 Million | 231.52 Million | -8.46 Million | 147.37 Million |
| Free Cash Flow | 68.56 Million | -934.1 Million | -683.39 Million | 335.07 Million | -481.2 Million | -783.49 Million |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -339.54 Million | -927.53 Million | -771.39 Million | -117.85 Million | -193.83 Million | 155.54 Million |
| Depreciation & Amortization | - | 786.06 Million | - | 205.79 Million | 192 Million | 187.8 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 90 Thousand | 91 Thousand | - | - | - |
| Change in working capital | - | 316.71 Million | - | - | - | - |
| Other non-cash items | 339.54 Million | 2.07 Billion | 771.3 Million | 117.85 Million | 193.83 Million | -155.54 Million |
| Investing Cash Flow | - | -677.26 Million | - | - | - | - |
| Investments in PPE | - | -605.75 Million | - | - | - | - |
| Acquisitions | - | 5.58 Million | - | - | - | - |
| Investment purchases | - | -77.92 Million | - | - | - | - |
| Sales/Maturities of investments | - | 830 Thousand | - | - | - | - |
| Other Investing Activities | - | -59.22 Million | - | - | - | - |
| Financing Cash Flow | - | -131.92 Million | - | - | - | - |
| Debt repayment | - | -252.13 Million | - | - | - | - |
| Dividends payments | - | -281.3 Million | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 5.8 Million | - | - | - | - |
| Other Financing Activities | - | -720.2 Million | - | - | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | 316.71 Million | - | - | - | - |
| Cash at beginning of period | - | 938.16 Million | - | 1.01 Billion | 1.2 Billion | 938.16 Million |
| Cash at end of period | - | 935.32 Million | - | -117.85 Million | 1.01 Billion | 155.54 Million |
| Capital Expenditure | - | -605.75 Million | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | -2.83 Million | - | -1.13 Billion | -193.83 Million | -782.61 Million |
| Free Cash Flow | - | 68.56 Million | - | -117.85 Million | -193.83 Million | 155.54 Million |
ALLEC
LECO
RIM
PRFT
NVFY
CITAF